Takeda family preps for a last-stand vote against Shire buyout; Eli Lilly reportedly shopping drug portfolio in China
→ Kunio Takeda’s last shot at derailing Takeda’s $62 billion takeover of Shire will take place during the big shareholder vote coming up on December …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
